We've found
6,502 Infectious Disease
clinical trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cytomegalovirus Infection Clinical Trial
Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases Clinical Trial
ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Status: Enrolling,
Phase
IV
Updated: 8/10/2016
Click here to add this to my saved trials
Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Clinical Trial
The Mycophenolate Pregnancy Registry
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fungal Infections Clinical Trial
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal, Other Clinical Trial
Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media
Status: Enrolling,
Phase
II
Updated: 3/18/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Chronic Hepatitis C Virus Infection Clinical Trial
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Status: Enrolling,
Phase
II
Updated: 4/14/2016
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 6/21/2017
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 6/21/2017
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Ophthalmology Clinical Trial
Cross-linking for Corneal Ulcers Treatment Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infection Clinical Trial
A Study to Evaluate the Safety of a Single IV Dose of Orbactiv (Oritavancin) in Subjects on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Status: Enrolling,
Phase
IV
Updated: 2/17/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Western Equine Encephalitis Clinical Trial
Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
We've found
6,502 Infectious Disease
clinical trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Herpes Zoster Clinical Trial
Updated: 3/10/2015
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)
Status: Enrolling,
Phase
III
Updated: 3/10/2015
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cytomegalovirus Infection Clinical Trial
Updated: 12/31/1969
Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases Clinical Trial
Updated: 8/10/2016
ZOSTAVAX™ (Zoster Vaccine Live) Long-term Effectiveness Study (V211-024)
Status: Enrolling,
Phase
IV
Updated: 8/10/2016
Click here to add this to my saved trials
Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases Clinical Trial
Updated: 8/1/2016
The Mycophenolate Pregnancy Registry
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Fungal Infections Clinical Trial
Updated: 12/31/1969
A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
Updated: 4/18/2014
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Human Papillomavirus Infection Clinical Trial
Updated: 4/18/2014
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
Status: Enrolling,
Phase
III
Updated: 4/18/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 4/22/2015
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-004)
Status: Enrolling,
Phase
I, II
Updated: 4/22/2015
Click here to add this to my saved trials
Immunology / Infectious Diseases, Musculoskeletal, Other Clinical Trial
Updated: 3/18/2014
Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media
Status: Enrolling,
Phase
II
Updated: 3/18/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
Updated: 3/2/2016
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
Updated: 3/2/2016
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
Updated: 3/2/2016
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
Updated: 3/2/2016
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling,
Phase
III
Updated: 3/2/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Bacterial Infection Clinical Trial
Updated: 4/12/2016
Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Status: Enrolling,
Phase
I
Updated: 4/12/2016
Click here to add this to my saved trials
Chronic Hepatitis C Virus Infection Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With and Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
Status: Enrolling,
Phase
II
Updated: 4/14/2016
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Study of Tedizolid Phosphate in Adolescents With Complicated Skin and Soft Tissue Infection (cSSTI) (MK-1986-012)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 6/21/2017
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 6/21/2017
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 6/21/2017
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 6/21/2017
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Updated: 12/31/1969
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Updated: 12/31/1969
A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Pneumococcal Infections Clinical Trial
Updated: 2/4/2016
A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)
Status: Enrolling,
Phase
I, II
Updated: 2/4/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Ophthalmology Clinical Trial
Updated: 12/31/1969
Cross-linking for Corneal Ulcers Treatment Trial
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology Clinical Trial
Updated: 12/31/1969
A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infection Clinical Trial
Updated: 2/17/2016
A Study to Evaluate the Safety of a Single IV Dose of Orbactiv (Oritavancin) in Subjects on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Status: Enrolling,
Phase
IV
Updated: 2/17/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 4/13/2016
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 4/13/2016
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 4/13/2016
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 4/13/2016
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 4/13/2016
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 4/13/2016
Pharmacokinetic and Safety Study of Ceftolozane/Tazobactam in Pediatric Participants Receiving Antibiotic Therapy for Proven or Suspected Gram-negative Infection or for Peri-operative Prophylaxis (MK-7625A-010)
Status: Enrolling,
Phase
I
Updated: 4/13/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/14/2016
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling,
Phase
III
Updated: 4/14/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Acute Bacterial Skin and Skin Structure Infections Clinical Trial
Updated: 6/13/2016
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Status: Enrolling,
Phase
III
Updated: 6/13/2016
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 4/12/2017
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling,
Phase
II
Updated: 4/12/2017
Click here to add this to my saved trials
Bacterial Infections Clinical Trial
Updated: 12/31/1969
Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Western Equine Encephalitis Clinical Trial
Updated: 12/31/1969
Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials
HIV INfections Clinical Trial
Updated: 11/29/2016
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Status: Enrolling
Updated: 11/29/2016
Click here to add this to my saved trials